166 related articles for article (PubMed ID: 31712777)
21. Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression.
Gran C; Luong V; Bruchfeld JB; Liwing J; Afram G; Lund J; Usmani S; Alici E; Nahi H
Am J Hematol; 2021 Mar; 96(3):E63-E65. PubMed ID: 33264449
[No Abstract] [Full Text] [Related]
22. [Cytogenetic study on 53 patients with multiple myeloma].
Jing Y; Fang MY; Jiang F; Lin S; Wang FT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):68-72. PubMed ID: 21362224
[TBL] [Abstract][Full Text] [Related]
23. An internationally recognized uniform cytogenetic classification system is needed for multiple myeloma.
Dispenzieri A
Leukemia; 2007 Jan; 21(1):9-11. PubMed ID: 17167528
[No Abstract] [Full Text] [Related]
24. Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
Ho M; Patel A; Goh CY; Moscvin M; Zhang L; Bianchi G
Leukemia; 2020 Dec; 34(12):3111-3125. PubMed ID: 33046818
[TBL] [Abstract][Full Text] [Related]
25. Smoldering multiple myeloma - Past, present, and future.
Mann H; Katiyar V; Varga C; Comenzo RL
Blood Rev; 2022 Mar; 52():100869. PubMed ID: 34312016
[TBL] [Abstract][Full Text] [Related]
26. [Cytogenetic study of multiple myeloma].
Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
[TBL] [Abstract][Full Text] [Related]
27. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
Boyle EM; Deshpande S; Tytarenko R; Ashby C; Wang Y; Bauer MA; Johnson SK; Wardell CP; Thanendrarajan S; Zangari M; Facon T; Dumontet C; Barlogie B; Arbini A; Rustad EH; Maura F; Landgren O; Zhan F; van Rhee F; Schinke C; Davies FE; Morgan GJ; Walker BA
Nat Commun; 2021 Jan; 12(1):293. PubMed ID: 33436579
[TBL] [Abstract][Full Text] [Related]
28. Prediction of cytogenetic abnormalities with gene expression profiles.
Zhou Y; Zhang Q; Stephens O; Heuck CJ; Tian E; Sawyer JR; Cartron-Mizeracki MA; Qu P; Keller J; Epstein J; Barlogie B; Shaughnessy JD
Blood; 2012 May; 119(21):e148-50. PubMed ID: 22496154
[TBL] [Abstract][Full Text] [Related]
29. Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma.
Rosiñol L; Carrió A; Bladé J; Queralt R; Aymerich M; Cibeira MT; Esteve J; Rozman M; Campo E; Montserrat E
Br J Haematol; 2005 Sep; 130(5):729-32. PubMed ID: 16115129
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
Baron F; Stevens-Kroef M; Kicinski M; Meloni G; Muus P; Marie JP; Halkes CJM; Thomas X; Vrhovac R; Specchia G; Lefrere F; Sica S; Mancini M; Venditti A; Hagemeijer A; Becker H; Jansen JH; Amadori S; de Witte T; Willemze R; Suciu S
Ann Hematol; 2018 Oct; 97(10):1785-1795. PubMed ID: 29926156
[TBL] [Abstract][Full Text] [Related]
31. [Molecular cytogenetic analyses of patients with plasma cell myeloma in Tolna and Baranya counties in Hungary].
Kosztolányi S; Horváth B; Hosnyánszki D; Kereskai L; Sziládi E; Jáksó P; Alizadeh H; Szuhai K; Alpár D; Kajtár B
Orv Hetil; 2019 Jun; 160(24):944-951. PubMed ID: 31433233
[TBL] [Abstract][Full Text] [Related]
32. RALE051: a novel established cell line of sporadic Burkitt lymphoma.
L'Abbate A; Iacobucci I; Lonoce A; Turchiano A; Ficarra E; Paciello G; Cattina F; Ferrari A; Imbrogno E; Agostinelli C; Zinzani P; Martinelli G; Derenzini E; Storlazzi CT
Leuk Lymphoma; 2018 May; 59(5):1252-1255. PubMed ID: 28893133
[No Abstract] [Full Text] [Related]
33. A retrospective analysis of cytogenetic and clinical characteristics in patients with multiple myeloma.
He J; Yang L; Meng X; Wei G; Wu W; Han X; Zheng G; Zheng W; Ye X; Shi J; Xie W; Zhang J; Huang H; Lin M; Cai Z
Am J Med Sci; 2013 Feb; 345(2):88-93. PubMed ID: 22986611
[TBL] [Abstract][Full Text] [Related]
34. SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status.
López-Corral L; Sarasquete ME; Beà S; García-Sanz R; Mateos MV; Corchete LA; Sayagués JM; García EM; Bladé J; Oriol A; Hernández-García MT; Giraldo P; Hernández J; González M; Hernández-Rivas JM; San Miguel JF; Gutiérrez NC
Leukemia; 2012 Dec; 26(12):2521-9. PubMed ID: 22565645
[TBL] [Abstract][Full Text] [Related]
35. High-throughput sample processing and sample management; the functional evolution of classical cytogenetic assay towards automation.
Ramakumar A; Subramanian U; Prasanna PG
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():132-41. PubMed ID: 26520383
[TBL] [Abstract][Full Text] [Related]
36. A cytogenetic methodology to evaluate in vitro the G2-chromosomal radiosensitization induced by chemicals at non-clastogenic doses.
Hatzi VI; Terzoudi GI; Makropoulos V; Pantelias GE
J Genet; 2009 Dec; 88(3):349-51. PubMed ID: 20086304
[No Abstract] [Full Text] [Related]
37. Identification of
Garcia JB; Storti P; Iannozzi NT; Marchica V; Agnelli L; Toscani D; Franceschi V; Todaro G; Sammarelli G; Notarfranchi L; Scita M; Palma BD; Raimondi V; Lungu O; Pruneri G; Donofrio G; Giuliani N
Haematologica; 2024 Feb; 109(2):627-631. PubMed ID: 37608776
[No Abstract] [Full Text] [Related]
38. Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders.
Ulaner GA; Landgren CO
Best Pract Res Clin Haematol; 2020 Mar; 33(1):101148. PubMed ID: 32139013
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic characterization of seven human cancer cell lines by combining G- and R-banding, M-FISH, CGH and chromosome- and locus-specific FISH.
Cottier M; Tchirkov A; Perissel B; Giollant M; Campos L; Vago P
Int J Mol Med; 2004 Oct; 14(4):483-95. PubMed ID: 15375617
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
